HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Zoltán Péterfi Selected Research

Clostridium Infections

1/2023Efficacy of lyophilised bacteria-rich faecal sediment and supernatant with reduced bacterial count for treating patients with Clostridioides difficile Infection - A novel method for capsule faecal microbiota transfer.
3/2021Fecal Microbiota Transplantation May Be the Best Option in Treating Multiple Clostridioides difficile Infection: A Network Meta-Analysis.
1/2021How to Apply FMT More Effectively, Conveniently and Flexible - A Comparison of FMT Methods.
6/2019Experiences with fecal microbiota transplantation in Clostridium difficile infections via upper gastrointestinal tract.
3/2019Faecal microbiota transplantation for Clostridium difficile infection using a lyophilized inoculum from non-related donors: A case series involving 19 patients.
2/2015Faecal microbiota transplantation in Clostridium difficile infections.
11/2014[Experience with fecal transplantation in the treatment of Clostridium difficile infection].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Zoltán Péterfi Research Topics

Disease

7Clostridium Infections
01/2023 - 11/2014
4Infections
10/2023 - 01/2014
2AIDS-Related Complex (ARC)
01/2021 - 04/2018
2Chronic Hepatitis C
01/2014 - 08/2013
1COVID-19
10/2023
1Dysbiosis
08/2023
1Migraine Disorders (Migraine)
08/2023
1Obesity
08/2023
1Pain (Aches)
08/2023
1Hematologic Neoplasms (Hematological Malignancy)
08/2023
1Hepatitis C
01/2022
1Chronic Obstructive Pulmonary Disease (COPD)
01/2021
1Bacterial Infections (Bacterial Infection)
01/2021
1Reinfection
11/2014
1Virus Diseases (Viral Diseases)
08/2013
1Necrosis
08/2013
1Appendicitis
04/2006

Drug/Important Bio-Agent (IBA)

2Antiviral Agents (Antivirals)IBA
01/2022 - 08/2013
2Pro-Opiomelanocortin (Proopiomelanocortin)IBA
01/2021 - 04/2018
2Ribavirin (Virazole)FDA LinkGeneric
01/2014 - 08/2013
2InterferonsIBA
01/2014 - 08/2013
1baricitinibIBA
10/2023
1Anti-Bacterial Agents (Antibiotics)IBA
08/2023
1Serotonin (5 Hydroxytryptamine)IBA
08/2023
1Capsules (Microcapsules)IBA
01/2023
1FidaxomicinIBA
01/2023
1ORALIT (ORS)IBA
01/2021
1Glucagon-Like Peptide 1 (GLP 1)IBA
01/2021
1VancomycinFDA LinkGeneric
01/2021
1Biomarkers (Surrogate Marker)IBA
01/2021
1Neuropeptide YIBA
04/2018
1RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA
06/2014
1Interleukin-4 (Interleukin 4)IBA
08/2013
1CytokinesIBA
08/2013
1Interleukin-2 (IL2)IBA
08/2013
1AntibodiesIBA
04/2006
1LipopolysaccharidesIBA
04/2006

Therapy/Procedure

4Fecal Microbiota Transplantation
08/2023 - 11/2014
3Therapeutics
08/2023 - 08/2013
2Transplantation
03/2019 - 02/2015